(Approval lapsed) Yaltormin SR 1000mg (metformin hydrochloride) Prolonged Release Tablets
Section 19A approved medicine
(Approval lapsed) Yaltormin SR 1000mg (metformin hydrochloride) Prolonged Release Tablets
Section 19A approval holder
Link Medical Products Pty Ltd ABN 73 010 971 516
Phone
1800 181 060
Approved until
Status
Expired
Medicines in short supply/unavailable
DIAFORMIN XR 1000 metformin hydrochloride 1000mg extended release tablet blister pack - ARTG 208441
DIABEX XR 1000 metformin hydrochloride 1000mg extended release tablet blister pack - ARTG 153699
APO-METFORMIN XR 1000 metformin hydrochloride 1000 mg modified release tablet blister pack - ARTG 281210
DIABEX XR 1000 metformin hydrochloride 1000mg extended release tablet blister pack - ARTG 153699
APO-METFORMIN XR 1000 metformin hydrochloride 1000 mg modified release tablet blister pack - ARTG 281210
Indication(s)
Treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. Yaltormin SR may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin.